CRESCENDO BIOSCIENCE
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.
CRESCENDO BIOSCIENCE
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.crescendobio.com
Total Employee:
51+
Status:
Closed
Contact:
(800) 469-7423
Email Addresses:
[email protected]
Total Funding:
166.68 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Font Awesome Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Google Google Cloud ASP.NET
Current Advisors List
Current Employees Featured
Founder
Investors List
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series D - Crescendo Bioscience
Skyline Ventures
Skyline Ventures investment in Series D - Crescendo Bioscience
Safeguard Scientifics
Safeguard Scientifics investment in Series D - Crescendo Bioscience
Kleiner Perkins
Kleiner Perkins investment in Series D - Crescendo Bioscience
Aeris Capital
Aeris Capital investment in Series D - Crescendo Bioscience
Kleiner Perkins
Kleiner Perkins investment in Series C - Crescendo Bioscience
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series C - Crescendo Bioscience
Aeris Capital
Aeris Capital investment in Series C - Crescendo Bioscience
Kleiner Perkins
Kleiner Perkins investment in Series B - Crescendo Bioscience
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series B - Crescendo Bioscience
More informations about "Crescendo Bioscience"
Crescendo Biologics - The T cell enhancing company
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024See details»
About Us - Crescendo Biologics
Beyond Crescendo’s proprietary pipeline, the Company has global, multi-target discovery and development collaborations with both Takeda and BioNTech and an exclusive, worldwide …See details»
Crescendo Biologics - Crunchbase Company Profile & Funding
Organization. Crescendo Biologics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Crescendo Biologics is engaged in …See details»
Crescendo Bioscience - PitchBook
Crescendo Bioscience General Information Description. Operator of a molecular diagnostics company focused in rheumatology. The company is focused on developing and …See details»
Crescendo Biologics - Org Chart, Teams, Culture & Jobs - The Org
View Crescendo Biologics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Crescendo Biologics Limited | LinkedIn
Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, …See details»
Crescendo Bioscience - Company Profile - Tracxn
Sep 6, 2024 Website: crescendobio.com; Social: Which legal entities is Crescendo Bioscience associated with? Crescendo Bioscience. is associated with 1 legal entity given below: Legal …See details»
Crescendo Bioscience - Crunchbase Company Profile & Funding
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory …See details»
Crescendo Biologics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Crescendo Biologics. Use the PitchBook Platform to explore the full profile.See details»
Crescendo Biologics - Craft
Crescendo Biologics has 5 employees at their 1 location, $116.2 m in total funding, and £7.51 m in annual revenue in FY 2018. See insights on Crescendo Biologics including office locations, …See details»
Crescendo Bioscience CEO, Founder, Key Executive Team, Board of ...
Crescendobio.com. Overview & Products; Financials; People; Alternatives & Competitors; Executives 17. Board of Directors 6. Crescendo Bioscience Management Team17 Team …See details»
Crescendo Bioscience | VentureRadar
Website: http://www.crescendobio.com. Crescendo Bioscience is a molecular diagnostics company focused in rheumatology and located in South San Francisco, CA.See details»
Myriad Genetics to Acquire Crescendo Bioscience®
Feb 4, 2014 Myriad Genetics to Acquire Crescendo Bioscience® SALT LAKE CITY, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it …See details»
Crescendo Biologics - Overview, News & Similar companies
Dec 6, 2023 Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo …See details»
Crescendo Bioscience - Owler
Crescendo Bioscience’s Profile, Revenue and Employees. Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune …See details»
Crescendo Biologics CEO and Key Executive Team | Craft.co
Crescendo Biologics's CDO is Philip Bland-Ward. Other executives include Theodora Harold, CEO and Director; Kevin Johnson, Chairman and 12 others. See the full leadership team at Craft.See details»
Myriad Autoimmune - Craft
Myriad Autoimmune (formerly known as Crescendo Bioscience) develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients …See details»
Crescendo Bioscience LLC - Drug pipelines, Patents, Clinical trials ...
Objective: To compare the multi-biomarker disease activity (MBDA) score with the DAS28-CRP and CRP for predicting risk of radiographic progression in patients with rheumatoid …See details»
Crescendo Bioscience Careers and Employment | Indeed.com
Oct 15, 2019 Find out what works well at Crescendo Bioscience from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Crescendo Biologics Announces Prestigious New Collaboration …
Oct 20, 2021 CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell …See details»